EU Pharma Reform, SPCs, Compulsory Licensing Among Parliament’s ‘Unfinished Business’

A number of legislative proposals will be coming under scrutiny at the newly constituted European Parliament in the coming months, including the pharma reform package and draft legislation on EU-level compulsory licensing and “unitary” supplementary protection certificates.

bundles bales of paper documents. stacks packs pile on the desk in the office
The European Parliament has identified 174 ongoing legislative dossiers • Source: Shutterstock

On 23 July, each of the new European Parliament’s 20 standing committees will hold a “constitutive” meeting during which they will elect a chair and up to four vice-chairs in preparation for the new legislative session.

They include the committee on the environment, public health and food safety (ENVI) and the legal affairs committee (JURI), which...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

  • EU Biosimilar Filings, Opinions And Approvals

     
    • By 

    <p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>

  • EU Pharma Reform: What You Need to Know Now

     

    As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.

  • New EU Approvals

    <p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>

More from Geography